Pulmonem Inc.
Research - Dieppe, New Brunswick, Canada
Pulmonem Inc. Employees
Georges-Henri Lavanchy
Vice-président Developpement commercial international
Pulmonem Inc. Senior Management
Pulmonem Inc. Details
Pulmonem Inc. was founded to demonstrate the effectiveness and safety of a reformulated and patented version of Dapsone, a generic drug, to arrest the development of inflammation caused by COVID-19 and help prevent hospitalization of those who become infected. Pulmonem has established manufacturing partnerships that will allow the Company to quickly bring this treatment to market soon after successful completion of clinical trials.Pulmonem is also pursuing solutions for the pediatric market, as well as alternative delivery systems, such as nasal sprays and liquids.
Pulmonem Inc. Technologies
Captcha
reCAPTCHA
Social Sharing
Facebook Like Button
Tag Management
Google Tag Manager
Social Login
Linkedin Login
Other
Mobile Friendly